Rudolf A. Baumgartner

1.4k total citations
38 papers, 1.1k citations indexed

About

Rudolf A. Baumgartner is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rudolf A. Baumgartner has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 18 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Rudolf A. Baumgartner's work include Asthma and respiratory diseases (20 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Rudolf A. Baumgartner is often cited by papers focused on Asthma and respiratory diseases (20 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Rudolf A. Baumgartner collaborates with scholars based in United States, Canada and Italy. Rudolf A. Baumgartner's co-authors include Michael A. Beaven, Koji Yamada, Cheng Zhang, John P. Hanrahan, Nicola A. Hanania, David P. Skoner, Anatoliy Senyshyn, Kenneth M. Yamada, Henry Milgrom and Steven A. Sahn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and CHEST Journal.

In The Last Decade

Rudolf A. Baumgartner

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rudolf A. Baumgartner United States 19 480 423 325 309 112 38 1.1k
Tsugio Nakazawa Japan 21 361 0.8× 213 0.5× 344 1.1× 491 1.6× 110 1.0× 49 1.2k
Kevin O’Brien United States 21 342 0.7× 188 0.4× 191 0.6× 323 1.0× 83 0.7× 62 1.3k
Ruth R. Osborn United States 15 743 1.5× 468 1.1× 362 1.1× 526 1.7× 156 1.4× 30 1.5k
Roy Pettipher United Kingdom 21 1.1k 2.2× 374 0.9× 604 1.9× 324 1.0× 354 3.2× 34 1.8k
J A Lindgren Sweden 8 513 1.1× 183 0.4× 373 1.1× 315 1.0× 176 1.6× 8 1.3k
Fumio Tsuji Japan 15 173 0.4× 54 0.1× 260 0.8× 221 0.7× 50 0.4× 45 864
Janina Wolf Germany 14 195 0.4× 112 0.3× 382 1.2× 482 1.6× 36 0.3× 15 1.2k
Yukiyoshi Ajisawa Japan 15 147 0.3× 70 0.2× 64 0.2× 271 0.9× 20 0.2× 23 951
Grzegorz Woszczek Poland 20 328 0.7× 109 0.3× 260 0.8× 214 0.7× 92 0.8× 39 834
Hui Shi China 20 107 0.2× 154 0.4× 246 0.8× 496 1.6× 7 0.1× 42 1.2k

Countries citing papers authored by Rudolf A. Baumgartner

Since Specialization
Citations

This map shows the geographic impact of Rudolf A. Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf A. Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf A. Baumgartner more than expected).

Fields of papers citing papers by Rudolf A. Baumgartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf A. Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf A. Baumgartner. The network helps show where Rudolf A. Baumgartner may publish in the future.

Co-authorship network of co-authors of Rudolf A. Baumgartner

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf A. Baumgartner. A scholar is included among the top collaborators of Rudolf A. Baumgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf A. Baumgartner. Rudolf A. Baumgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laties, Alan M., et al.. (2016). A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers. Journal of Ocular Pharmacology and Therapeutics. 32(8). 548–554. 18 indexed citations
2.
3.
Myers, Jonathan S., et al.. (2013). A Randomized, Phase II Study of Trabodenoson (INO-8875) in Adults with Ocular Hypertension (OHT) or Primary Open-Angle Glaucoma (POAG). Investigative Ophthalmology & Visual Science. 54(15). 2621–2621. 7 indexed citations
4.
Crosson, Craig E., et al.. (2010). INO-8875, an Adenosine A1 Agonist, Lowers Intraocular Pressure Through the Conventional Outflow Pathway. Investigative Ophthalmology & Visual Science. 51(13). 3238–3238. 6 indexed citations
5.
Hanania, Nicola A., James F. Donohue, Harold S. Nelson, et al.. (2010). The Safety and Efficacy of Arformoterol and Formoterol in COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 7(1). 17–31. 20 indexed citations
6.
Crosson, Craig E., et al.. (2009). INO-8875, An Adenosine A1 Agonist, in Development for Open-Angle Glaucoma Reduces IOP in Three Rabbit Models. Investigative Ophthalmology & Visual Science. 50(13). 4061–4061. 8 indexed citations
7.
Hanrahan, John P., Donna R. Grogan, Rudolf A. Baumgartner, et al.. (2008). Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD). Medicine. 87(6). 319–328. 48 indexed citations
8.
Nair, Parameswaran, Jonathan Corren, Warren Pleskow, et al.. (2008). A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. Journal of Allergy and Clinical Immunology. 122(3). 544–549. 8 indexed citations
9.
Hanrahan, John P., et al.. (2008). Effect of Nebulized Arformoterol on Airway Function in COPD: Results from Two Randomized Trials. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(1). 25–34. 36 indexed citations
10.
11.
Baumgartner, Rudolf A., et al.. (2007). Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clinical Therapeutics. 29(2). 261–278. 55 indexed citations
12.
Nowak, Richard M., Charles L. Emerman, John P. Hanrahan, et al.. (2006). A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. The American Journal of Emergency Medicine. 24(3). 259–267. 39 indexed citations
13.
Skoner, David P., et al.. (2005). Evaluation of the Safety and Efficacy of Levalbuterol in 2-5-year-Old Patients with Asthma. Pediatric Pulmonology. 40(6). 477–486. 29 indexed citations
14.
Baumgartner, Rudolf A., Jonathan M. Edelman, Gabriel Gómez, et al.. (2003). Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. European Respiratory Journal. 21(1). 123–128. 44 indexed citations
15.
Milgrom, Henry, et al.. (2001). Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. Journal of Allergy and Clinical Immunology. 108(6). 938–945. 85 indexed citations
16.
Zhang, Cheng, Rudolf A. Baumgartner, Koji Yamada, & Michael A. Beaven. (1997). Mitogen-activated Protein (MAP) Kinase Regulates Production of Tumor Necrosis Factor-α and Release of Arachidonic Acid in Mast Cells. Journal of Biological Chemistry. 272(20). 13397–13402. 196 indexed citations
17.
Baumgartner, Rudolf A., et al.. (1996). Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. The Journal of Immunology. 157(9). 4087–4093. 46 indexed citations
18.
Beaven, Michael A. & Rudolf A. Baumgartner. (1996). Downstream signals initiated in mast cells by FcεRI and other receptors. Current Opinion in Immunology. 8(6). 766–772. 75 indexed citations
19.
Baumgartner, Rudolf A., Koichiro Ozawa, J R Cunha-Melo, et al.. (1994). Studies with transfected and permeabilized RBL-2H3 cells reveal unique inhibitory properties of protein kinase C gamma.. Molecular Biology of the Cell. 5(4). 475–484. 7 indexed citations
20.
Baumgartner, Rudolf A., et al.. (1994). Secretion of TNF from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process.. The Journal of Immunology. 153(6). 2609–2617. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsugio Nakazawa Breakdown of academic impact, for papers by Kevin O’Brien Breakdown of academic impact, for papers by Ruth R. Osborn Breakdown of academic impact, for papers by Roy Pettipher Breakdown of academic impact, for papers by J A Lindgren Breakdown of academic impact, for papers by Fumio Tsuji Breakdown of academic impact, for papers by Janina Wolf Breakdown of academic impact, for papers by Yukiyoshi Ajisawa Breakdown of academic impact, for papers by Grzegorz Woszczek Breakdown of academic impact, for papers by Hui Shi
Rankless by CCL
2026